Wednesday, February 5
(Whitehouse Station, NJ) -- Drug maker Merck is reporting quarterly sales that are just short of analysts' expectations. Revenue for the fourth quarter of last year dropped to eleven-point-32-billion dollars, while Wall Street had predicted Merck's revenue would be eleven-point-36-billion. America's second-biggest drug manufacturer says earnings for the quarter totaled 781-million dollars. The New Jersey-based company says it was hurt by sales of cheaper generic medicines from other providers.